Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Calidi Biotherapeutics, Inc. has filed 392 SEC EDGAR filings since 17 May 2021

SEC filing history

Showing 101-125 of 392 matching filings.

Per page
25
Current page
5
424B5 File 333-282456

424B5 filing

Filing date
10 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-282456

424B5 filing

Filing date
08 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283741

EFFECT filing

Filing date
27 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Dec 2024
Reporting date
17 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283741

UPLOAD filing

Filing date
17 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-282456

424B5 filing

Filing date
29 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-282456

424B5 filing

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92875

CALIDI BIOTHERAPEUTICS, INC.

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-282456

424B5 filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40789

10-Q filing

Filing date
12 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
25-NSE File 001-40789

25-NSE filing

Filing date
28 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-282456

424B5 filing

Filing date
24 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-282456

424B5 filing

Filing date
23 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Oct 2024
Reporting date
20 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Oct 2024
Reporting date
20 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .